{"url":"https://lda.senate.gov/api/v1/filings/f9291baf-cf3d-45e5-bb50-a87dd22ec79b/","filing_uuid":"f9291baf-cf3d-45e5-bb50-a87dd22ec79b","filing_type":"RR","filing_type_display":"Registration","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f9291baf-cf3d-45e5-bb50-a87dd22ec79b/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2024-08-07T11:24:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2855 Gazelle Court","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Carlsbad","registrant_state":"CA","registrant_zip":"92010","registrant":{"id":401108715,"url":"https://lda.senate.gov/api/v1/registrants/401108715/","house_registrant_id":56573,"name":"IONIS PHARMACEUTICALS, INC.","description":null,"address_1":"2855 Gazelle Court","address_2":null,"address_3":null,"address_4":null,"city":"Carlsbad","state":"CA","state_display":"California","zip":"92010","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BETH ANNE COLE","contact_telephone":"+1 760-348-8517","dt_updated":"2026-07-19T12:32:47.660355-04:00"},"client":{"id":61063,"url":"https://lda.senate.gov/api/v1/clients/61063/","client_id":61063,"name":"IONIS PHARMACEUTICALS, INC.","general_description":"Biotechnology company.","client_government_entity":null,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the implementation of the Inflation Reduction Act. H.R.5547/S.476 - Maintaining Investments in New Innovation Act. H.R.7384 - Creating Hope Reauthorization Act of 2024. H.R.7085 - BIOSECURE Act.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":147257,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to the implementation of the Inflation Reduction Act. H.R.5547/S.476 - Maintaining Investments in New Innovation Act. H.R.7384 - Creating Hope Reauthorization Act of 2024. H.R.7085 - BIOSECURE Act.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":147257,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"CHAPMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}